共 50 条
Botulinum toxin therapy for spasmodic torticollis. Medical and non-medical adjunct treatment
被引:0
|作者:
Leplow, B.
[1
]
Boettcher, M.
[1
]
Schoenfeld, R.
[1
]
机构:
[1] Univ Halle Wittenberg, Inst Psychol, D-06120 Halle, Germany
来源:
关键词:
Botulinum toxin;
Spasmodic torticollis;
Personality;
Anxiety;
Depression;
QUALITY-OF-LIFE;
CERVICAL DYSTONIA;
FOCAL DYSTONIA;
DEPRESSION;
IMPACT;
BLEPHAROSPASM;
DETERMINANTS;
MANAGEMENT;
ANXIETY;
D O I:
10.1007/s00115-012-3708-1
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Background. Spasmodic torticollis patients were investigated with respect to the number of adjunct treatments used before and after the introduction of botulinum toxin therapy (Btx). The study was designed in a similar way to an earlier investigation by Birner et al. (Nervenarzt 70:903-908, 1999). Material and methods. A total of 247 patients with idiopathic spasmodic torticollis were assessed at three time points for the diagnosis: before 1988 (n=63), between 1989 and 1998 (n=107) and after 1999 (n=77). Results. Independent of the year of diagnosis patients underwent a mean of 14.3 different treatments. In addition to Btx most of the patients were subjected to massage, physiotherapy, medication and a large number of non-medical treatments including praying. No associations to clinical or personal variables were found. Those patients with emotional disorders prior to onset of dystonia displayed a higher rate of medical and non-medical treatments in addition to Btx. Conclusions. The results confirmed those found by Birner et al.. In order to enhance compliance patients should undergo psycho-education with respect to illness behaviour and specific history taking with respect to emotional disorders prior to dystonia.
引用
收藏
页码:493 / 497
页数:5
相关论文